(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were down on Tuesday ahead of third-quarter GDP data that could feed into the Federal Reserve's decision on whether to raise interest rates next month. Dow Jones industrial average futures were down 0.48 percent at 17,677, S&P 500 futures were down 0.53 percent at 2,073.25 and Nasdaq 100 futures were down 0.56 percent at 4,649.75.
** PALO ALTO NETWORKS INC, Monday close $172.02, +2.90 pct premarket
The cyber security company forecast current quarter sales that beat market expectations and reported higher-than-expected quarterly revenue as companies and governments spent more to protect themselves from cyber attacks.
** TIFFANY & CO, Monday close $76.55, -4.73 pct premarket
The upscale jeweler’s quarterly sales fell 2.2 percent as a strong dollar hurt tourist spending in the United States and reduced the value of sales from other markets.
** BRISTOL-MEYERS SQUIBB CO, Monday close $67.99, +0.75 pct premarket
The U.S. Food and Drug Administration has approved Bristol-Myers’ drug, Opdivo, for treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer.
** XEROX CORP, Monday close $10.75, +3.72 pct premarket
Activist investor Carl Icahn disclosed a stake in Xerox and called the printer and copier maker’s shares “undervalued”.
** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Monday close $87.41, +3.99 pct premarket
Activist investor Bill Ackman’s hedge fund has significantly increased its investment in the Canadian drugmaker and signaled it may play a greater role in the beleaguered drugmaker’s strategy, according to a regulatory filing.
** BOEING CO, Monday close $148.34
** AEROJET ROCKETDYNE HOLDINGS INC, Monday close $16.25
Aerojet Rocketdyne on Monday announced contracts from NASA and the Chicago-based aircraft maker Boeing with a combined value of nearly $1.36 billion, welcome news for the company after several recent financial setbacks.
** SUNEDISON INC, Monday close $3, +10.00 pct premarket
The solar company plans to sell solar power capacity worth about 400 megawatts in India for roughly $350 million, as the U.S.-based firm looks to shed assets to boost balance sheet, said two sources with direct knowledge of the matter.
** CVS HEALTH CORP, Monday close $91.56
** AMGEN INCO, Monday close $162.47
** REGENERON PHARMACEUTICALS INC, Monday close $570.85
** SANOFI SA, Monday close $43.88, -1.46 pct premarket
U.S. drug benefit manager CVS Health said on Monday it would add Amgen’s Repatha cholesterol treatment to its list of covered drugs for private plans over a competing treatment from Regeneron and Sanofi.
** EMERGENT BIOSOLUTIONS INC, Monday close $37.74
The U.S. Food and Drug Administration approved to expand the use of Emergent’s anthrax vaccine to prevent suspected or confirmed exposure to the bacterium that causes the disease. (Compiled by Rachel Chitra in Bengaluru; Editing by Maju Samuel)